Biosimilar Concept & Rixathon Clinical Trial
Speaker: Dr. Amar Lal Affiliations: Consultant Hematologist, Tawam Hospital, Al Ain, United Arab Emirates This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.
Speaker: Dr. Arif Alam Affiliations: Division Chief of Hematology Clinic, Tawam Hospital, United Arab Emirates This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.
Speaker: Dr. Elias Jabbour Affiliations: Professor of Medicine in the Department of Leukemia, University of Texas MD Anderson Cancer Center, United States This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020.
Speaker: Dr. Andrew Davies Affiliations: Director, Southampton Experimental Cancer Medicine Center, United Kingdom This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.
Speaker: Dr. John M. Pagel Affiliations: Chief of Hematologic Malignancies, Swedish Cancer Institute, United States This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.
Speaker: Dr. Pau Montesinos Affiliations: Attending Physician in Department of Hematology, University Hospital La Fe, Valencia, Spain This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.
Speaker: Dr. Amar Lal Affiliations: Consultant Hematologist, Tawam Hospital, Al Ain, United Arab Emirates This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022
Speaker: Dr. Khalil Al Farsi Affiliations: Senior Consultant in the Hematology/BMT Department, Sultan Qaboos University Hospital, Muscat, Oman This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2022.
Speaker: Dr. Amar Lal Affiliations: Consultant Hematologist, Tawam Hospital, Al Ain, United Arab Emirates This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2021.
Speaker: Dr. Elias Jabbour Affiliations: Professor of Medicine in the Department of Leukemia, University of Texas MD Anderson Cancer Center, United States This topic was presented during the Emirates Society of Haematology virtual educational series hosted in 2020